Statens Serum Institut

GLP-1 Receptor Agonists Not Linked to Increased Suicide Risk, Study Finds

5 months ago

• A nationwide study in France found no increased risk of suicide or suicide attempts associated with GLP-1 receptor agonists (GLP-1 RAs). • The research included patients with psychiatric disorders and obesity, addressing a gap in previous clinical trials. • The study used a case-time-control design to account for confounding factors and exposure-trend bias, enhancing the reliability of the findings. • Results showed a negative association between GLP-1 RA use and suicidal behaviors, suggesting short-term psychiatric safety.